Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards

Abstract

PURPOSE To provide standards for medically integrated dispensing of oral anticancer drugs and supportive care medications. METHODS An Expert Panel was formed, and a systematic review of the literature on patient-centered best practices for the delivery of oral anticancer and supportive care drugs was performed to April 2019 using PubMed and Google Scholar. Available patient-centered standards, including one previously developed by the National Community Oncology Dispensing Association (NCODA), were considered for endorsement. Public comments were solicited and considered in preparation of the final manuscript. RESULTS A high-quality systematic review that was current to May 2016 was adopted into the evidence base. Five additional primary studies of multifaceted interventions met the inclusion criteria. These studies generally included a multicomponent intervention, often led by an oncology pharmacist, and also included patient education and regular follow-up and monitoring. These interventions resulted in significant improvements to patient quality and safety and demonstrated improvements in adherence and other patient outcomes. CONCLUSION The findings of the systematic review were consistent with the NCODA patient-centered standards for patient relationships and education, adherence, safety, collection of data, documentation, and other areas. NCODA standards were adopted and used as basis for these American Society of Clinical Oncology/NCODA standards. Additional information is available at www.asco.org/mid-standards .

Taboo Topics in Adolescent and Young Adult Oncology: Strategies for Managing Challenging but Important Conversations Central to Adolescent and Young Adult Cancer Survivorship

“…Nevertheless, oncologists should be skilled in "primary" palliative care delivery, including facile communication about end of life and goals of care. 140 Several communication techniques and resources have been proposed in the oncology literature, including programs offering in-person trainings focused on communication, web-based curricula, and quick guides with mnemonics or suggested phrases. 97,[141][142][143][144][145][146][147] All of these are helpful when discussing the possibility or inevitability of a patient's death.…”

Psychosocial determinants of adherence with oral anticancer treatment: ‘we don’t need no education’

“…Jacobs et al, who emphasize the importance of exploring illness perceptions and medication beliefs in efforts to motivate patients to continue taking their oral anticancer treatment 30]. Recently, ASCO/NCODA Standards appear to integrate these suggestions to a certain extent, which must be judged as encouraging [50].…”

The Role of Oncology Pharmacists in optimizing patient care in Chronic Immune Thrombocytopenia

“…For example, patients who receive corticosteroids should be aware of the risks of short-term and long-term adverse effects [26]. Oncology pharmacists also should be involved in counseling patients on the proper administration of agents used for chronic immune thrombocytopenia (e.g., avoidance of specific vitamins and antacids with eltrombopag and the importance of taking avatrombopag with food) [26].Additionally, if a splenectomy is a preferred treatment, oncology pharmacists can ensure that the patient is upto-date on recommended vaccinations to mitigate the risk of infection. Monitoring for drug-drug interactions is essential for patients with chronic immune thrombocytopenia who are treated with drug therapy.…”